Reducing Hereditary Cancer Act

Reducing Hereditary Cancer Act

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Bill 118 HR 1526, also known as the Reducing Hereditary Cancer Act, is a piece of legislation introduced in the US Congress. The main goal of this bill is to address the issue of hereditary cancer by providing increased access to genetic testing and counseling for individuals who may be at risk.

The bill proposes to establish a grant program that would provide funding to healthcare providers to offer genetic testing and counseling services to individuals with a family history of certain types of cancer. This would help identify individuals who may be at an increased risk of developing hereditary cancer and allow them to take proactive steps to manage their risk.

Additionally, the bill aims to improve education and awareness around hereditary cancer by requiring the Department of Health and Human Services to develop and implement a public education campaign. This campaign would provide information on the importance of genetic testing and counseling for individuals with a family history of cancer. Overall, the Reducing Hereditary Cancer Act seeks to address the issue of hereditary cancer by increasing access to genetic testing and counseling services, as well as improving education and awareness around the topic. This bill has the potential to have a significant impact on individuals at risk for hereditary cancer and could help save lives through early detection and prevention measures.